Decitabine Plus R-CHOP in Diffuse Large B-cell Lymphoma

Clinical trial NCT02951728 · UNKNOWN

Trial details

NCT number: NCT02951728
Sponsor: Ruijin Hospital
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma

Start date: 2016-10-01
Primary completion: 2019-05-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.